The Autonomous City of Ceuta has put out to tender the execution of the antigen test service and SARS-COV2 vaccination.
With an estimated value of the contract of 577,735.92 euros and an amount of 282,867.96 euros, the object of the contract is “the service of carrying out antigen tests and vaccination in compliance with the Surveillance Strategies and Vaccination, approved by the commission of Public health” for a period of one year with the possibility of extension for another year.
However, as part of the clarification, they explain that “in the event that vaccination is included within the usual or seasonal campaigns, or until the circulation of SARS-COV-2 is prolonged at a low level, the contract will be will understand defeated “.
In the content of the economic report on the cost of contracting for the antigen test and vaccination service, in addition to detailing the duration of one year, they specify that there are five hours a day from Monday to Friday, with five workers, an ambulance and else material sanitario.
Within the classification, they detail that these are services provided by medical personnel and nurses. This is an open ordinary processing procedure with presentation of the electronic offer, with the deadline for obtaining the specifications until February 9 at 11:59 p.m.
As part of the annexes, the insufficiency report is added, which highlights that the Ministry of Health, Consumption and the Interior, “lacks its own personnel and means to carry out the service at home or transfer in case of emergency.”
Covid-19 surveillance
Regarding the justification of the need, they have recalled that among the powers of the council is “the study, surveillance and epidemiological analysis of the processes that affect, positively or negatively, human health”, so that within the within its sphere of competence, it carries out, among other things, “the surveillance of Covid-19”.
They have also stressed that “the Surveillance and Control Strategy against Covid-19 after the acute phase of the pandemic in force since 03/23/2022, revised on November 8, 2022, document approved by the Report on Alerts and Preparedness and Response Plans and by the Public Health Commission of the National Health System It has among its objectives the surveillance, prevention and control of active infection by SARS-CoV-2 and with special monitoring of the epidemiological evolution in vulnerable areas and groups”.
Regarding the evaluation of the impact of Covid-19, they have insisted on the need to “monitor changes in the epidemiological patterns of the disease as well as the appearance of new variants that may condition a worse evolution of the epidemic, in order to take action early.”
